Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir for Prevention of HCC Recurrence in Low Viral Load Chronic Hepatitis B
NCT02308319Phase 4Unknown
- Sponsor
- Samsung Medical Center
- Start
- Jan 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate in hepatocellular carcinoma (HCC), sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02308319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02308319.